Insmed (INSM) is down -15.9%, or -$31.63 to $166.83.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSM:
- Insmed falls -18.4%
- Insmed: Managing CRSsNP Setback While Leveraging a Diversified, Innovation-Rich Respiratory Pipeline to Support Buy Rating and $230 Target
- Insmed price target lowered to $230 from $240 at H.C. Wainwright
- Insmed price target lowered to $241 from $269 at TD Cowen
- Insmed price target lowered to $203 from $214 at BofA